Japan· JP-8114401A2135
モルヒネ塩酸塩水和物
A morphine product containing モルヒネ塩酸塩水和物, registered in Japan by 武田薬品工業, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Morphine is registered in 16 of 19 countries.
Countries holding a registration under ATC N02AA01 (morphine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 9 of them publish a price we can compare per daily dose
Morphine · ATC N02AA01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of morphine costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Morphine · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.69
- IT Italy$1.94
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- モルヒネ塩酸塩水和物
- Manufacturer
- 武田薬品工業
- Country
- Japan (JP)
- ATC code
- N02AA01
- ATC class
- Morphine
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
865 interactions on record for morphine.
Graded by severity as the source publishes them — 131 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Morphine · interactions on record
865 records
- 131 severe
- 336 moderate
- 9 minor
- 377 info
Most severe, free to view
- TriflupromazinA04AD06severe
- AlvimopanA06AH02severe
- EthanolB05XX04severe
- ChlorphenesinD01AE07severe
12 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N02AA01
Morphine, as other registers publish it.
- United KingdomActimorph 10mg orodispersible tabletsEthypharm UK Ltd
- United KingdomActimorph 1mg orodispersible tabletsEthypharm UK Ltd
- United KingdomActimorph 2.5mg orodispersible tabletsEthypharm UK Ltd
- United KingdomActimorph 20mg orodispersible tabletsEthypharm UK Ltd
- United KingdomActimorph 30mg orodispersible tabletsEthypharm UK Ltd
- United KingdomActimorph 5mg orodispersible tabletsEthypharm UK Ltd
- PolandAutostrzykawka Morfina Przeciwko BólowiZakład Produkcji Sprzętu Medycznego RAVIMED Sp. z o.o.
- GermanyCaprosEthypharm
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d93aead2-a362-4b2e-b99f-4bc7dd9b2597 GET /v1/drugs/d93aead2-a362-4b2e-b99f-4bc7dd9b2597?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "1%5mL1管",
"marks": "局 麻",
"source": "mhlw",
"remarks": null,
"yj_code": "8114401A2135",
"category": "注射薬",
"price_yen": 1371,
"generic_name": "モルヒネ塩酸塩水和物",
"product_name_jp": null,
"therapeutic_class": "8114",
"transitional_expiry": null
}See everything about morphine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.